AzTrials
AzTrials

Urinary IncontinenceNCT06337240

Pelvic Floor Exercises Versus Pilates on Urinary Incontinance in Chronic Obstructive Pulmonary Disease

An observational study of Urinary Incontinence, run by Cairo University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of the study is To compare between the effect of both pelvic floor and Pilates exercises on urinary incontinences in COPD patients. Read more about this study

Who is it for?
Ages 50 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Urinary Incontinence
What is being tested?
Pelvic floor on COPD patients and Pilates exercises on COPD patients
How many people
60 participants
Where
1 siteEgypt
Study dates
29 Mar 2024to 2 Jul 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Group A (study group) : This group will include 30 COPD patients with urinary incontinence , who will receive pelvic floor exercise for 3 days a week for a total of 3 months. Group B (study group): This group will include 30 COPD patients with urinary incontinence , who will receive Pilates for 3 days a week for a total 3 months.

Who may be able to join

  • Patients diagnosed with COPD \& Urinary incontinence
  • Stable with moderate to severe COPD
  • Their ages will range from fifty years old.
  • All patients will be clinically stable.

Who cannot join

  • Gynecologic surgery ( 6 months prior to study)
  • Current urinary tract infection
  • Uncontrolled Diabetes Mellitus
  • Diagnosed with psychiatric or depressive disorder
  • Existing arterial aneurysm.
  • Clinical signs of unstable cardiac event (eg, congestive heart failure),
Show all 10Show fewer
  • Severe arterial hypertension,
  • Neurological disorders that will affect pelvic floor muscles.
  • Acute COPD exacerbation within the last 4 weeks.
  • Any need for supplemental oxygen.

Trial locations and contacts

1 site in 1 country.

Egypt1 site, 1 recruiting
  • Faculty of Physical Therapy

    Cairo

    Donia El masry, doctorate, 01005587119, donia.elmasry@cu.edu.eg

    Recruiting

Other trials in Egypt

About this study

The aim of the study is To compare between the effect of both pelvic floor and Pilates exercises on urinary incontinences in COPD patients.

Read the detailed description

Urinary incontinence (UI) is defined as loss of bladder control and is characterized by the complaint of any involuntary leakage of urine UI is an important individual and social problem, in that it is associated with worse health-related quality of life (HRQoL) in subjects with chronic obstructive pulmonary disease. Although UI is not a life-threatening condition, it is common and can have numerous negative psychological, social, and economical effects. Women with UI in the general population have higher levels of depression, anxiety and stress, poor sleep quality and significantly lower HRQL Additionally, long term UI may result in absence from work, increased healthcare costs, social isolation and physical inactivity which is common from the early stages of the COPD due to dyspnea. Furthermore, inactivity is associated with risk of hospital admissions and is a strong predictor for mortality. The combination of UI and COPD may therefore result in a double risk factor in terms of exercise avoidance and the subsequent negative consequences of inactivity.

As it could be concluded that urinary incontinence is a trouble problem that can change the life of COPD patients and therapy attempts to prevent it or control it will be appreciated, taking in consideration that all people nowadays prefer to choose the most safe method of their conditions.

Being tested
Pelvic floor on COPD patients, Pilates exercises on COPD patients
Medical subject headings
Urinary Incontinence

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pelvic floor on COPD patientsOther

    Group A (study group) :

    This group will include 30 COPD patients with urinary incontinence , who will receive pelvic floor exercise for 3 days a week for a total of 3 months.

  • Pilates exercises on COPD patientsOther

    Group B (study group):

    This group will include 30 COPD patients with urinary incontinence , who will receive pilates for 3 days a week for a total 3 months.

Study groups in NCT06337240
Study groupRoleWhat they receive
Pelvic floor exercises on COPD patients30 COPD female patients with urinary incontinence will receive pelvic floor exercises.
Receives: Other: Pelvic floor on COPD patients; Other: Pilates exercises on COPD patients

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Urinary incontinence (1 Hour and 24- Hour pad test)

    Pad testing is a non-invasive method of detecting and quantifying severity of urine leakage in men or women.

    Measured: 3 months

  2. Incontinence severity index:

    Incontinence Severity Index (ISI), consisting of two questions regarding frequency (four levels) and amount (three levels) of leakage. The validity of the ISI has been demonstrated for different types of UI and has received the highest recommendation from the 2nd and 3rd International Consultation on Incontinence

    Measured: 3 months

Secondary outcomes (4)
  1. Urinary incontinence quality of life questionnaire (I-QOL)

    Incontinence Quality of Life (I-QOL), a condition-specific instrument designed to measure the QOL effects of UI in women. The I-QOL contains 22 items with a 5-point Likert-type response scale yielding a total score and three subscale scores (i.e., avoidance and limiting behaviors, psychosocial impacts, and social embarrassment) with good to excellent test-retest reliability

    Measured: 3 months

  2. Cough symptoms score

    its reliability and treatment response have been confirmed The CSS is a two-part questionnaire referring to daytime and night-time symptoms. Based on the frequency, intensity and influence of cough on daily activities and sleep, cough symptoms are scored from 0 to 5, with 0 indicating no cough and 5 indicating the most severe cough

    Measured: 3 months

  3. Cough symptoms questionnaire

    It is a questionnaire consisting of 19 items, including 8 physical items, 7 psychological items and 4 social items. Each item is rated according to the frequency of occurrence with a score ranging from 1 to 7. The regional score is the sum of items scored divided by the items (score 1-7) in each area; the total score is the sum of the regional scores.The lower the score, the more serious the impact of chronic cough un quality of life

    Measured: 3 months

  4. The COPD Assessment Tool (CAT)

    This COPD-specific questionnaire evaluates the overall burden in subjects with COPD using 8 different questions. Each question can be scored from 0 points (not impaired) to 5 points (maximally impaired). Accordingly, the total score can range from 0 to 40 points, with higher scores reflecting greater burden of the disease.

    CAT questionnaire consisting of eight questions regarding cough, phlegm, chest tightness, breathlessness during activities, activity limitations at home, confidence in leaving home, sleep and energy. The scoring range of each item is between 0 and 5, with a maximum score of 40.

    According to the total CAT scores, the patients were included in the following stages:

    Stage 1: <10 Stage 2: 10-20 Stage 3: >20 Stage 4: >30(

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Mar 2024
  2. Study start29 Mar 2024 (estimated)
  3. Primary completion2 Jul 2024 (estimated)
  4. Study completion2 Jul 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06337240
Sponsor's protocol ID
pelvic floor exercise
Status last verified
Mar 2024
First submitted
15 Mar 2024
Last updated
29 Mar 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Abrams P, Andersson KE, Birder L, Brubaker L, Cardozo L, Chapple C, Cottenden A, Davila W, de Ridder D, Dmochowski R, Drake M, Dubeau C, Fry C, Hanno P, Smith JH, Herschorn S, Hosker G, Kelleher C, Koelbl H, Khoury S, Madoff R, Milsom I, Moore K, Newman D, Nitti V, Norton C, Nygaard I, Payne C, Smith A, Staskin D, Tekgul S, Thuroff J, Tubaro A, Vodusek D, Wein A, Wyndaele JJ; Members of Committees; Fourth International Consultation on Incontinence. Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn. 2010;29(1):213-40. doi: 10.1002/nau.20870. No abstract available.

    PubMed 20025020

Questions about this trial

What is this clinical trial studying?

An observational study of Urinary Incontinence, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Rana Ali, Master (01016157507, doctorranaaymanpt@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Urinary incontinence (1 Hour and 24- Hour pad test) (time frame: 3 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06337240, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Mar 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in